Health Industry Innovation Alliance Members Sign Memorandum Of Understanding On Improving Pharmaceutical Ecosystem

Monday, November 13, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Beijing Rogrand E-commerce Co., Ltd convenes industry leaders on sidelines of APEC CEO Summit Viet Nam 2017

DA NANG, Vietnam, Nov. 12, 2017 /PRNewswire/ -- The Health Industry Innovation Alliance (HIIA), a consortium of leading Chinese pharmaceutical manufacturers,

distributors, venture capital partners and e-commerce companies, announced that its members signed a memorandum of understanding to improve the pharmaceutical ecosystem domestically and throughout the Asia-Pacific region.

On the sidelines of the APEC CEO Summit Viet Nam 2017, executives of HIIA member companies expressed their commitment to partnering together to provide personalized, affordable and accessible healthcare to people by building a more efficient supply chain of healthcare products and services. 

"By fostering partnership, mutual trust, inclusiveness and shared success between players across the healthcare spectrum, we are building a better healthcare model that makes people healthier and happier," said Ms. Yao Xiaofei, Chairwoman and CEO, Beijing Rogrand E-commerce Co., Ltd and co-founder of HIIA.  "The private sector has a strong opportunity, and a responsibility, to help guide us towards a better healthcare future – and we are proud to take on the challenge together."

Executives who joined Ms. Yao in signing the memorandum included:

  • Mr. Chen Changqing, President, Beijing Rogrand E-commerce Co., Ltd
  • Mr. Ma Zhanjun, Chairman of the Board, Sinopharm Group Hubei Co., Ltd
  • Mr. Wang Yongcheng, CEO, Beijing Medi'care Ltd
  • Mr. Xiao Weihong, CEO, Shenyang Sunshine Pharmaceutical Co., Ltd
  • Mr. Zhang Chunbo, Vice President, Guangzhou Baiyunshan Medicine Group Co., Ltd
  • Mr. Zeng Zhiqiang, Managing Partner, HG Captital Fund Management Co., Ltd
  • Mr. Huang Bin, Chairman of the Board, AstraZeneca Pharmaceuticals (China) Co., Ltd
  • Mr. Wu Feng, Head of Commercial & Diversified Business Group, Pfizer Investment Co., Ltd (China)
  • Mr. Hong Yinchun, Business District Manager, Xian-Janssen Pharmaceutical Ltd

The memorandum was signed as HIIA members prepare for the second APEC China Health Industry Forum, to be held in Beijing in December 2017.  HIIA was founded following the first APEC China Health Industry Forum in 2016.

The Forum is the private sector's response to APEC Leaders' "Health Asia-Pacific 2020" initiative.  In 2014, APEC Leaders launched the initiative to reaffirm their commitment to recognizing health as a critical component of economic and trade development and a driver of regional economic growth.

View original content:http://www.prnewswire.com/news-releases/health-industry-innovation-alliance-members-sign-memorandum-of-understanding-on-improving-pharmaceutical-ecosystem-300554340.html

SOURCE Rogrand E-commerce



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store